Dagmar Dolby Sells 50,000 Shares of Dolby Laboratories, Inc. (DLB) Stock

Dolby Laboratories, Inc. (NYSE:DLB) major shareholder Dagmar Dolby sold 50,000 shares of the stock in a transaction on Monday, June 11th. The stock was sold at an average price of $64.31, for a total value of $3,215,500.00. The transaction was disclosed in a document filed with the SEC, which is available through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Friday, June 8th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.25, for a total value of $3,212,500.00.
  • On Wednesday, June 6th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $64.36, for a total value of $3,218,000.00.
  • On Monday, June 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.93, for a total value of $6,293,000.00.
  • On Thursday, May 31st, Dagmar Dolby sold 17,439 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.67, for a total value of $1,092,902.13.
  • On Tuesday, May 29th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.54, for a total value of $6,154,000.00.
  • On Thursday, May 24th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $61.50, for a total value of $6,150,000.00.
  • On Tuesday, May 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.31, for a total value of $6,231,000.00.
  • On Friday, May 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.49, for a total value of $6,249,000.00.
  • On Wednesday, May 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.82, for a total value of $6,282,000.00.
  • On Monday, May 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $62.65, for a total value of $6,265,000.00.

NYSE:DLB traded up $0.59 during trading hours on Thursday, hitting $65.20. The company’s stock had a trading volume of 8,763 shares, compared to its average volume of 418,657. The firm has a market capitalization of $6.70 billion, a PE ratio of 29.63, a price-to-earnings-growth ratio of 2.32 and a beta of 0.76. Dolby Laboratories, Inc. has a twelve month low of $48.00 and a twelve month high of $74.29.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Tuesday, April 24th. The electronics maker reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.64 by $0.14. The business had revenue of $301.36 million for the quarter, compared to analyst estimates of $300.37 million. Dolby Laboratories had a return on equity of 12.73% and a net margin of 7.64%. Dolby Laboratories’s revenue was up 12.7% compared to the same quarter last year. During the same period last year, the firm posted $0.63 earnings per share. sell-side analysts anticipate that Dolby Laboratories, Inc. will post 2.31 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 16th. Investors of record on Monday, May 7th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend was Friday, May 4th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 29.09%.

Several analysts have recently issued reports on the company. Barrington Research reissued a “buy” rating and set a $78.00 target price on shares of Dolby Laboratories in a report on Tuesday, May 1st. Zacks Investment Research lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Friday, April 27th. Finally, ValuEngine raised Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $66.50.

Large investors have recently added to or reduced their stakes in the stock. Elkfork Partners LLC acquired a new stake in Dolby Laboratories in the fourth quarter valued at about $102,000. Captrust Financial Advisors acquired a new stake in Dolby Laboratories in the fourth quarter valued at about $122,000. Cornerstone Capital Management Holdings LLC. acquired a new stake in Dolby Laboratories in the fourth quarter valued at about $145,000. Meadow Creek Investment Management LLC acquired a new stake in Dolby Laboratories in the fourth quarter valued at about $179,000. Finally, Eagle Boston Investment Management Inc. bought a new position in Dolby Laboratories in the fourth quarter valued at about $202,000. 54.05% of the stock is currently owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit